New oral anticoagulants and the cancer patient
NJ Short, JM Connors - The oncologist, 2014 - academic.oup.com
Learning Objectives Cite the current indications, basic clinical pharmacology, and rationale
for development of the new oral anticoagulants. Explain the potential risk for drug-drug …
for development of the new oral anticoagulants. Explain the potential risk for drug-drug …
[PDF][PDF] New Oral Anticoagulants and the Cancer Patient
NJ Short, JM Connors - The Oncologist, 2014 - Wiley Online Library
Indications for anticoagulation are common in patients with malignancy. Cancer patients
have an increased risk of developing venous thromboembolic events or may have other …
have an increased risk of developing venous thromboembolic events or may have other …
New oral anticoagulants and the cancer patient
NJ Short, JM Connors - Oncologist, 2014 - mdanderson.elsevierpure.com
Abstract ndications for anticoagulation are common in patients with malignancy. Cancer
patients have an increased risk of developing venous thromboembolic events or may have …
patients have an increased risk of developing venous thromboembolic events or may have …
[PDF][PDF] New Oral Anticoagulants and the Cancer Patient
NJ SHORT, JM CONNORS - researchgate.net
Indications for anticoagulation are common in patients with malignancy. Cancer patients
have an increased risk of developing venous thromboembolic events or may have other …
have an increased risk of developing venous thromboembolic events or may have other …
New Oral Anticoagulants and the Cancer Patient.
NJ Short, JM Connors - Oncologist, 2014 - search.ebscohost.com
Indications for anticoagulation are common in patients with malignancy. Cancer patients
have an increased risk of developing venous thromboembolic events or may have other …
have an increased risk of developing venous thromboembolic events or may have other …
New oral anticoagulants and the cancer patient
NJ Short, JM Connors - The oncologist, 2014 - pubmed.ncbi.nlm.nih.gov
Indications for anticoagulation are common in patients with malignancy. Cancer patients
have an increased risk of developing venous thromboembolic events or may have other …
have an increased risk of developing venous thromboembolic events or may have other …
New Oral Anticoagulants and the Cancer Patient
NJ Short, JM Connors - The Oncologist, 2013 - cir.nii.ac.jp
抄録< jats: title> Learning Objectives</jats: title>< jats: p> Cite the current indications, basic
clinical pharmacology, and rationale for development of the new oral anticoagulants …
clinical pharmacology, and rationale for development of the new oral anticoagulants …
[HTML][HTML] New Oral Anticoagulants and the Cancer Patient
NJ Short, JM Connors - The Oncologist, 2014 - ncbi.nlm.nih.gov
Indications for anticoagulation are common in patients with malignancy. Cancer patients
have an increased risk of developing venous thromboembolic events or may have other …
have an increased risk of developing venous thromboembolic events or may have other …
[PDF][PDF] New Oral Anticoagulants and the Cancer Patient
NJ SHORT, JM CONNORS - Citeseer
Indications for anticoagulation are common in patients with malignancy. Cancer patients
have an increased risk of developing venous thromboembolic events or may have other …
have an increased risk of developing venous thromboembolic events or may have other …
New oral anticoagulants and the cancer patient.
NJ Short, JM Connors - The Oncologist, 2013 - europepmc.org
Indications for anticoagulation are common in patients with malignancy. Cancer patients
have an increased risk of developing venous thromboembolic events or may have other …
have an increased risk of developing venous thromboembolic events or may have other …